Tempus AI, Inc..
TEM.US | Research and experimental development on natural sciences and engineering
Tempus AI, Inc. is a technology company focused on precision medicine. It has developed an AI-enabled platform that provides genomic sequencing and data analysis to healthcare providers, particularly oncologists. The company's platform helps physicians personalize cancer treatments by analyzing pati...Show More
Better Health for All
30
Tempus AI's core business, including its AI-enabled platform, genomic sequencing, data analysis, and clinical trial matching, is entirely focused on improving patient outcomes and advancing cancer and cardiovascular research, indicating 100% of its portfolio delivers revolutionary health benefits. The company generates no revenue from products with negative health outcomes. Tempus Next is deployed across more than 80 hospitals with over 60 cardiovascular algorithms and has expanded into oncology.
1
The company is connected to over 50% of all oncologists in the U.S.
2
Tempus helps clinicians provide timely and accurate diagnostics and therapies for all patients, regardless of socioeconomic status. At a large academic medical center, AI-driven cardiac care for aortic stenosis and mitral regurgitation showed a larger decrease in average time from index echo to follow-up for Black patients (120 to 64 days) compared to White patients (57 to 36 days).
3
Tempus publishes on the quality of its data and enables users to trace data points back to the source text.
4
The company invests in AI-driven solutions and an underlying data platform to simplify and secure data sharing. Tempus's AI tools integrate into EHRs to act as a safety net for clinicians, reminding them of recommended tests, which helps relieve stress and burnout.
5
Tempus Next includes screening algorithms for abdominal aortic aneurysms and thoracic aortic aneurysms, and identifies patients at risk of sudden cardiac arrest, left atrial appendage thrombus, and atrial fibrillation.
6
Tempus is governed by HIPAA, de-identifies protected health information (PHI) as early as possible, and uses strict, role-based access controls.
7
Tempus accelerates patient accrual to clinical trials and provides infrastructure for efficiently launching Phase 1 trials.
8
Fair Money & Economic Opportunity
0
Tempus AI, Inc. is a technology company focused on precision medicine, providing genomic sequencing and data analysis to healthcare providers. The company does not offer lending, deposit, or other consumer financial services.
1
Therefore, all KPIs related to financial products, lending practices, customer financial outcomes, or financial literacy initiatives are not applicable to its core business model. While Tempus's platform connects with over 2,500 institutions for bidirectional data flow,
2
this pertains to healthcare data, not customer finance data or open-banking APIs.
Fair Pay & Worker Respect
0
Insufficient evidence to determine a value score for Tempus AI, Inc. regarding Fair Pay & Worker Respect. No articles or relevant information found. A neutral score of 0 is assigned.
Materiality Analysis: Company Summary (75-100 words): Tempus AI is a healthcare technology company providing molecular diagnostics, genomic sequencing, and clinical data analytics to healthcare providers, pharmaceutical companies, and researchers. Its core business involves analyzing patient data to improve cancer treatment and drug development. Key offerings include genomic testing services, clinical trial matching, and data analytics platforms. The company operates primarily in the United States, with collaborations with pharmaceutical companies like AstraZeneca. It is headquartered in Chicago, Illinois.
Peer Comparison (50-75 words): Compared to other healthcare technology and diagnostics companies, Tempus AI's impact on "Fair Pay & Worker Respect" is typical. It is expected to adhere to standard labor laws and provide competitive compensation. Benchmarking data on pay ratios and safety incidents would be needed to assess relative performance.
Materiality Assessment (1-2 clear sentences): The business model has a medium level of materiality to "Fair Pay & Worker Respect" because as a technology and lab services provider, Tempus AI has direct responsibilities to its employees regarding wages, safety, and fair labor practices.
Detailed Rationale (150-200 words): Tempus AI's operations require a skilled workforce of scientists, data analysts, software engineers, and lab technicians. Fair compensation, safe working conditions in labs, and equitable treatment are essential for attracting and retaining talent. While the company does not have significant supply chain risks related to forced labor, its internal labor practices are critical. Key considerations include ensuring competitive wages, providing comprehensive health insurance, maintaining a safe lab environment, and promoting diversity and inclusion. Employee engagement and turnover rates will be important indicators of worker satisfaction. Labor law violations or discrimination lawsuits would be significant red flags. The company's growth trajectory and reliance on specialized skills make fair pay and worker respect crucial for its long-term success.
Value Interaction Notes (if applicable, 25-50 words): N/A
Scoring Boundary Flags (if applicable, 25-50 words): Scores indicating systemic labor violations or extremely low health insurance coverage would be illogical. A score suggesting widespread use of insecure contracts would also be inconsistent with the need for specialized, skilled employees.
Fair Trade & Ethical Sourcing
0
Tempus AI, Inc. operates as a technology company specializing in precision medicine, offering genomic sequencing and data analysis services.
1
Its business model, as described, does not involve the procurement or trade of physical commodities, nor does it have a supply chain that typically requires fair-trade certifications, audits for labor practices, or traceability of raw materials.
2
Therefore, all KPIs related to fair trade and ethical sourcing are assessed as N/A, as the company's operations do not fall within the scope of these metrics.
3
Honest & Fair Business
-30
Tempus AI has a Whistleblower Policy, approved on February 1, 2024, and effective June 14, 2024.
1
This policy prohibits retaliation for good faith reporting of suspected misconduct by employees and third parties, offering anonymous channels including a Compliance Hotline and a secure web form.
2
The Compliance Officer is responsible for receiving, reviewing, and investigating complaints.
3
The company has a Comprehensive Compliance Program, last modified January 1, 2025, which includes policies and procedures for ethical interactions with healthcare professionals and an annual dollar limit on educational items and promotional activities.
4
However, the effectiveness metrics for its FCPA-compliant policy and training are not provided. A securities class action lawsuit was filed on June 12, 2025, alleging that Tempus overstated its AI capabilities and inflated contract values, some with related parties.
5
The lawsuit also alleges that Tempus-acquired Ambry had a business model based on aggressive and potentially unethical business practices.
6
Additionally, allegations suggest that board members and executives have been associated with troubled companies that restated financial results, and a May 2025 report from Spruce Point Capital questioned management practices and financial reporting.
7
Kind to Animals
0
Tempus AI, Inc. is a technology company focused on precision medicine, providing an AI-enabled platform for genomic sequencing and data analysis. Its core business model does not involve animal agriculture, animal-derived products, or direct impact on wildlife habitats, rendering several KPIs not applicable. Tempus uses and offers patient-derived organoids (PDOs) and organoid-based screening as a rapid and cost-effective alternative to *in vivo* preclinical animal experiments for drug screening and target validation.
1
The company has invested in expanding its patient-derived organoid capabilities.
2
While the company's platform offers alternatives to animal models, there is no explicit information on its participation in multi-stakeholder initiatives for animal-free standards or its public policy engagement on animal welfare.
No War, No Weapons
0
The company states it does not engage in transactions with sanctioned parties or embargoed countries and conducts export transactions in accordance with U.S. export and re-export controls and sanctions laws.
1
Its software terms of use require institutions to certify compliance with data handling restrictions related to 'Countries of Concern' and 'Covered Persons,' and to terminate user privileges if a user becomes an employee or contractor of such entities within one business day of awareness.
2
The company's core business involves services like genomic sequencing and data analysis, which are not described as having military applications, and there is no evidence of AI systems being used militarily. The company's operations do not involve weapons, thus red lines for such are not applicable, nor is there exposure to controversial weapons.
Planet-Friendly Business
0
No evidence available to assess Tempus AI, Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
Tempus AI has no reported cultural appropriation incidents.
1
The company's operations in precision medicine and data analytics do not inherently impact cultural contexts, and therefore, no specific cultural impact assessment protocol is mentioned.
2
Safe & Smart Tech
0
Tempus AI maintains CLIA and CAP accreditations for its laboratories and holds ISO 27001 certification.
1
The company conducts annual employee security training, including periodic phishing and social engineering simulations.
2
Tempus states it uses secure storage and transmission technologies, including encryption, and has patents related to data encryption and anonymization.
3
The company's privacy policy, last revised May 1, 2024, outlines user rights for data access, deletion, and correction for California, EU, and UK residents.
4
Tempus maintains a vulnerability management policy, conducts vulnerability scans, penetration tests, social engineering simulations, and third-party red/blue team testing.
5
The company's privacy program is designed to support and enhance its cybersecurity program, including annual HIPAA Security Risk Assessments.
6
Tempus states compliance with HIPAA, GDPR, CCPA, and the Washington My Health My Data Act.
7
Zero Waste & Sustainable Products
-30
Tempus AI has implemented several waste reduction initiatives focused on e-waste, including offering zero-landfill recycling, commodities resale, eco-friendly recycling with R2- and e-Stewards-certified partners, repurposing and reuse of viable devices, remarketing devices, and the GreenGiving program for IT asset disposition.
1
The company states that e-waste is toxic and that improper disposal can lead to fines and lawsuits due to violations of EPA regulations, GDPR, and state laws.
2
Tempus AI uses NIST and DoD-compliant data destruction services and provides certificates of data destruction.
3
There are no reported waste disposal violations in the past three years.
4
The company holds ISO 9001 and ISO 14001 certifications, and works with R2- and e-Stewards-certified partners for recycling, but no facilities are explicitly stated to have zero waste certification.
5